Aignosis funding, investors and company details

Aignosis is an emerging Healthcare startup from Jaipur, working in the space of Startup developing an AI-powered developmental screening platform for early detection of autism spectrum disorder. Founded by Raksheet Jain, Divyansh Mangal.

Company: Aignosis Artificial Intelligence Private Limited
Sector: Healthcare
Location: Jaipur
Founders: Raksheet Jain, Divyansh Mangal
Total funding raised: ₹4 Cr

Company overview

Aignosis is an Indian healthtech startup developing an AI-powered developmental screening platform for early detection of autism spectrum disorder in children. Its software uses a standard laptop and webcam to evaluate children between the ages of sixteen months and nine years, analyzing pediatric behavior across nine specialized stimulus modules — tracking micro-expressions, eye-gaze fixation, name response lag, and social interactions — and generating a standardized clinical risk report to guide specialized pediatric referrals. The five-minute, non-invasive screening tool is designed to make neurodevelopmental diagnosis accessible and affordable for pediatricians, developmental centres, and hospitals across India.

Funding rounds

Latest round (Seed): ₹4.00 Cr. ($ 0.41 Mn), 2026-10-05. Investors: Antler India, Nikhil Kamath, Varun Dua, IIMA Ventures